Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000152

EVP, COO sold 69 shares at $430.93 ($29,734)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Arbuckle Stuart A · EVP, COO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-15 Sale : show line 1 in the form 10b5-1 −69 $430.93 $29,734 49,691 D
Open-market sales · 69 sh · avg $430.93 · $29,734
Loading xslF345X05/wk-form4_1715977463.xml…